T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Fidelity National Information Services
FIS
|
+$3.15B |
| 2 |
NextEra Energy, Inc.
NEE
|
+$1.96B |
| 3 |
Global Payments
GPN
|
+$1.95B |
| 4 |
Salesforce
CRM
|
+$1.48B |
| 5 |
Boeing
BA
|
+$1.47B |
Top Sells
| 1 |
WP
Worldpay, Inc.
WP
|
+$3.23B |
| 2 |
DATA
Tableau Software, Inc.
DATA
|
+$1.76B |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$1.49B |
| 4 |
Bank of America
BAC
|
+$1.45B |
| 5 |
Pfizer
PFE
|
+$1.22B |
Sector Composition
| 1 | Technology | 19.69% |
| 2 | Healthcare | 15.84% |
| 3 | Financials | 13.92% |
| 4 | Consumer Discretionary | 13.43% |
| 5 | Industrials | 10.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Credicorp
BAP
$20.9B
| $660M | 0.09% |
3,166,544
+428,922
| +16% | +$89.4M |
|
|
CLGX
227
DELISTED
Corelogic, Inc.
CLGX
| $659M | 0.09% |
14,237,628
-9,311
| -0.1% | -$431K |
|
228
Union Pacific
UNP
$127B
| $656M | 0.09% |
4,051,833
+609,859
| +18% | +$98.8M |
|
229
Loews
L
$19.9B
| $653M | 0.09% |
12,675,186
-3,186,462
| -20% | -$164M |
|
|
NATI
230
DELISTED
National Instruments Corp
NATI
| $651M | 0.09% |
15,503,696
+5,495,886
| +55% | +$231M |
|
231
GSK
GSK
$81.5B
| $651M | 0.09% |
12,195,035
+71,315
| +0.6% | +$3.8M |
|
232
Mondelez International
MDLZ
$80.3B
| $650M | 0.09% |
11,743,007
+679,868
| +6% | +$37.6M |
|
|
XLNX
233
DELISTED
Xilinx Inc
XLNX
| $641M | 0.09% |
6,685,642
-472,004
| -7% | -$45.3M |
|
234
Sherwin-Williams
SHW
$89B
| $640M | 0.09% |
3,489,240
+513,924
| +17% | +$94.2M |
|
235
Armstrong World Industries
AWI
$8.44B
| $638M | 0.09% |
6,594,260
+122,247
| +2% | +$11.8M |
|
|
GLIBA
236
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
| $637M | 0.09% |
10,270,063
+33,239
| +0.3% | +$2.06M |
|
237
VF Corp
VFC
$5.82B
| $635M | 0.09% |
7,137,400
+1,332,934
| +23% | +$119M |
|
238
Abbott
ABT
$225B
| $634M | 0.09% |
7,579,361
+227,561
| +3% | +$19M |
|
|
PRAH
239
DELISTED
PRA Health Sciences, Inc.
PRAH
| $632M | 0.09% |
6,370,056
+1,670,484
| +36% | +$166M |
|
240
International Paper
IP
$24.5B
| $631M | 0.09% |
15,923,825
-5,006,591
| -24% | -$198M |
|
241
Lennox International
LII
$19.6B
| $630M | 0.09% |
2,593,208
+400,938
| +18% | +$97.4M |
|
242
Corning
GLW
$64B
| $627M | 0.09% |
21,987,537
-2,390,188
| -10% | -$68.2M |
|
243
FirstService
FSV
$9.35B
| $626M | 0.09% |
6,107,723
-2,175
| -0% | -$223K |
|
244
Enovis
ENOV
$1.74B
| $625M | 0.09% |
12,487,383
+561,143
| +5% | +$28.1M |
|
245
Franco-Nevada
FNV
$38.2B
| $621M | 0.09% |
6,809,399
-4,490,479
| -40% | -$409M |
|
246
Neurocrine Biosciences
NBIX
$14B
| $606M | 0.09% |
6,730,360
+3,348,591
| +99% | +$302M |
|
247
Johnson Controls International
JCI
$70.3B
| $599M | 0.08% |
13,658,419
-2,920,078
| -18% | -$128M |
|
248
Northern Trust
NTRS
$24.2B
| $590M | 0.08% |
6,325,095
+103,759
| +2% | +$9.68M |
|
|
RP
249
DELISTED
RealPage, Inc.
RP
| $587M | 0.08% |
9,339,195
+337,895
| +4% | +$21.2M |
|
250
Analog Devices
ADI
$122B
| $585M | 0.08% |
5,236,882
-400,047
| -7% | -$44.7M |
|